Industry Insights
-
The Importance Of Recording Zero In The Digital Age
4/9/2024
Explore the value of negative results and how proper data management enables your digital maturity journey towards scientific advancement.
-
The Need For Mass Produced Spheroids
10/26/2023
Researchers looking for reliable ways to recapitulate physiological conditions are turning to spheroids and other 3D objects, seeking ways to mass-produce 3D models for various applications.
-
Biotech Wasn't Ready For AI's Speed; Here's How We Catch Up
12/5/2025
Computational success is no stand-in for therapeutic readiness. Innovators must learn to discern between models rooted in science and those that speculate.
-
7 Reasons To Embrace AI-Enabled Digital Validation
5/6/2025
Are you overwhelmed by paperwork during validation projects? Discover how AI-enabled validation can streamline operations, strengthen compliance, and keep you ahead in the fast-paced pharmaceutical and biotech industries.
-
Partnering For Scalable Suspension Processes Tailored To AAV Therapies
Achieving optimized, scalable suspension processes for adeno-associated virus (AAV)-based therapeutics comes with a number of technical and business challenges.
-
Understanding CQAs For mRNA/Lipid Nanoparticle Product Development And Manufacture
12/13/2023
BioPhorum recently created a resource of potential critical quality attributes (CQAs) for mRNA products from the early stages of drug development to commercial manufacturing. We asked two of the paper’s authors some questions to explore the key areas in more detail.
-
Report: Nearly 40% Of Biomanufacturers Eyeing Continuous Processing
8/19/2025
Continuous perfusion manufacturing came about before the technology was mature enough to support it. Now, new data suggests an inflection point in the status quo.
-
The Science Of Cell Line Development For Biologics
2/12/2026
Selecting and engineering the right cell line is not simply a technical milestone; it is a strategic decision that shapes cost of goods, development timelines, and the overall probability of success.
-
Mitigate Human Error And Improve Performance In Pharma QC
7/17/2023
Gain insight into how the Quality Control team at Almac Sciences developed processes and strategies to help ensure a high quality of safe and effective products while also maximizing efficiency.
-
Strategies For Minimizing The Impact Of Bioburden And Sterility Testing On Gene Therapy Batch Yield
1/2/2024
It is widely recognized that gene therapy manufacturing processes result in low yields. This article outlines strategies for reducing the volumes required for bioburden and sterility testing and, therefore, conserving product for patients while remaining compliant and delivering process information on the microbiological status.